Constructional apraxia in frontotemporal dementia associated with the C9orf72 mutation: Broadening the clinical and neuropsychological phenotype

References

• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC Hexanucleotide Repeat in Non-coding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245–56.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population based cohort study. Lancet Neurol. 2012;11:232–40.
   PubMed Web of Science ®Google Scholar
• Boeve BF, Boylan KB, Graff-Radford NR, DeJesus- Hernandez M, Knopman DS, Pedraza O, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9orf72. Brain. 2012;135:765–83.
   PubMed Web of Science ®Google Scholar
• Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, et al. Clinical and pathological features of familial frontotemporal dementia caused by C9orf72 mutation on chromosome 9p. Brain. 2012;135:709–22.
   PubMed Web of Science ®Google Scholar
• Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, et al. Frontotemporal dementia with the C9orf72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain. 2012;135:736–50.
   PubMed Web of Science ®Google Scholar
• Simón-Sánchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, et al. The clinical and pathological phenotype of C9orf72 hexanucleotide repeat expansions. Brain. 2012;135:723–35.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9orf72 mutations. Brain. 2012;135:693–708.
   PubMed Web of Science ®Google Scholar
• Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, et al. Frontotemporal dementia due to C9orf72 mutations: clinical and imaging features. Neurology. 2012; 79:1002–11.
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9orf72, tau, progranulin and sporadics. Brain. 2012;135:794–806.
   PubMed Web of Science ®Google Scholar
• Sabatelli M, Conforti FL, Zollino M, Mora G, Monsurrò MR, Volanti P, et al. C9orf72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging. 2012;33:1848–53.
   PubMed Web of Science ®Google Scholar
• Chiò A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9orf72. Brain. 2012;135:784–93.
   PubMed Web of Science ®Google Scholar
• Piazza A, Mayr WR, Contu L, Amoroso A, Borelli I, Curtoni ES, et al. Genetic and population structure of four Sardinian villages. Ann Hum Genet. 1985;49:47–63.
   PubMed Web of Science ®Google Scholar
• Cavalli-Sforza LL, Piazza A, Menozzi P, Mountain J. Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data. Proc Natl Acad Sci U S A. 1988;85:6002–6.
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76: 1006–14.
   PubMed Web of Science ®Google Scholar
• Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:157–9.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Spinnler H, Tognoni G. Standardizzazione e Taratura Italiana di Test Neuropsicologici. Ital J Neurol Sci. 1987;8: 1–50.
   PubMedGoogle Scholar
• Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G. Verbal and spatial immediate memory span. Normative data from 1355 adults and 1112 children. Ital J Neurol Sci. 1987;8:539–48.
   PubMedGoogle Scholar
• Carlesimo GA, Caltagirone C, Gainotti G, Nocentini Ue il gruppo per la standardizzazione della batteria per il deterioramento mentale: batteria per la valutazione del deterioramento mentale (parte II): standardizzazione ed affidabilità diagnostica nell'identificazione di pazienti affetti da sindrome demenziale. Archivio di Psicologia, Neurologia e Psichiatria. 1995;56:471–87.
   Google Scholar
• Novelli G, Papagno C, Capitani E, Laiacona M, Vallar G, Cappa SF. Tre test clinici di ricerca e produzione lessicale: taratura su soggetti normali. Archivio di Psicologia, Neurologia e Psichiatria. 1986;47:477–506.
   Google Scholar
• Nocentini U, Di Vincenzo S, Panella M, Pasqualetti P, Caltagirone C. La valutazione delle funzioni esecutive nella pratica neuropsicologica: dal Modified Card Sorting Test al Modified Card Sorting test-Roma version. Dati di standardizzazione. Neurologia. 2002;12:14–24.
   Google Scholar
• Cafarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Una versione abbreviata del test di Stroop: dati normativi nella popolazione Italiana. Rivista Neurol. 2002;12:111–5.
   Google Scholar
• Miceli G, Burani C, Laudanna A. Batteria per l'analisi dei deficit afasici. Milano, ASRN, 1991.
   Google Scholar
• Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test Manual revised and expanded. PAR, 1993.
   Google Scholar
• Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–14.
   PubMed Web of Science ®Google Scholar
• Chiò A, Borghero G, Pugliatti M, Ticca A, Calvo A, Moglia C, et al. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol. 2011;68:594–8.
   PubMedGoogle Scholar
• Cannas A, Borghero G, Floris GL, Solla P, Chiò A, Traynor BJ, et al. The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson’s disease and other degenerative Parkinsonisms. Neurogenetics. 2013;14: 161–6.
   PubMed Web of Science ®Google Scholar
• Galimberti D, Fenoglio C, Serpente M, Villa C, Bonsi R, Arighi A, et al. Autosomal dominant frontotemporal lobar degeneration due to the C9orf72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry. 2013;74:384–91.
   PubMed Web of Science ®Google Scholar
• Marrosu MG, Lai M, Cocco E, Loi V, Spinicci G, Pischedda MP, et al. Genetic factors and the founder effect explain familial MS in Sardinia. Neurology. 2002;22;283–8.
   Google Scholar
• Pugliatti M, Parish LD, Cossu P, Leoni S, Ticca A, Saddi MV, et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009. J Neurol. 2013;260:572–9.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Mendez FM, Lauterbach EC, Sampson SM, ANPA Committee on Research. An evidence based review of the psychopathology of frontotemporal dementia: a report of the ANPA committee on research. J Neuropsychiatry Clin Neurosci. 2008;20:130–48.
   PubMed Web of Science ®Google Scholar
• Lillo P, Hodges JR. Cognition and behaviour in motor neuron disease. Curr Opin Neurol. 2010;23:638–42.
   PubMed Web of Science ®Google Scholar
• Devenney E, Hornberger M, Irish M, Mioshi E, Burrell J, Tan R, et al. Frontotemporal Dementia Associated With the C9orf72 Mutation: A Unique Clinical Profile. JAMA Neurol. 2014;71:331–9.
   PubMed Web of Science ®Google Scholar
• Bak TH, Yancopoulou D, Nestor PJ, Xuereb JH, Spillantini MG, Pulvermüller F, et al. Clinical, imaging and pathological correlates of hereditary deficit in verb and action processing. Brain. 2006;129:321–32.
   PubMed Web of Science ®Google Scholar
• Yokoyama JS, Rosen HJ. Neuroimaging features of C9orf72 expansion. Alzheimer's Research & Therapy. 2012;4:45.
   Google Scholar
• Hillis AE, Sangjiin O, Ken L. Deterioration of naming nouns versus verbs in primary progressive aphasia. Ann Neurol. 2004;55:268–75.
   PubMed Web of Science ®Google Scholar
• Floris G, Borghero G, Cannas A, Di Stefano F, Costantino E, Murru MR, et al. Frontotemporal dementia with psychosis, Parkinsonism, visuospatial dysfunction, upper motor neuron involvement associated to expansion of C9orf72: a peculiar phenotype? J Neurol. 2012;259: 1749–51.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Rollinson S, Lafon C, Harris J, Thompson J, Richardson AM, et al. Psychosis, C9orf72 and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2012; 83:1031–2.
   Google Scholar
• McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863–72.
   PubMed Web of Science ®Google Scholar